Call For More Transparency In Clinical Trials
Tuesday, January 29, 2013 - 18:40
in Health & Medicine
Pharmaceuticals are in decline as an industry due to over-regulation, lawsuits and cultural distrust. A new initiative from the European Medicines Agency, to commit to releasing all of the information from clinical trials once the marketing authorization process has ended, is being cheered by proponents of access to data but the pharmaceutical industry is less pleased. Writing in an editorial, PLoS Medicine writes, "As 2013 begins, it is clear that critical times lie ahead for the publishing of clinical trials, which may define the relationship between pharmaceutical companies and the public for many years to come. read more
Read the whole article on Scientific Blogging
More from Scientific Blogging
Related
- Misleading media coverage of medicineWed, 26 Nov 2008, 10:23:04 EST
- Public disclosure of clinical trial results by Health Canada should be mandatoryTue, 30 Aug 2011, 8:34:21 EDT
- Project Zero Delay accelerates drug's path to clinical trialMon, 3 Aug 2009, 16:24:58 EDT
- Clinical study of epilepsy drug may have been purely promotionalMon, 27 Jun 2011, 22:33:42 EDT
- Results from TH-302 clinical trials presented at international lung cancer meetingThu, 6 Aug 2009, 17:30:56 EDT